IT1243742B - Calcitonin-based pharmaceutical compositions - Google Patents

Calcitonin-based pharmaceutical compositions

Info

Publication number
IT1243742B
IT1243742B IT02173590A IT2173590A IT1243742B IT 1243742 B IT1243742 B IT 1243742B IT 02173590 A IT02173590 A IT 02173590A IT 2173590 A IT2173590 A IT 2173590A IT 1243742 B IT1243742 B IT 1243742B
Authority
IT
Italy
Prior art keywords
calcitonin
pharmaceutical compositions
based pharmaceutical
monobasic
citrate
Prior art date
Application number
IT02173590A
Other languages
Italian (it)
Other versions
IT9021735A1 (en
IT9021735A0 (en
Inventor
Pasquale Pantisano
Evaristo Bertone
Original Assignee
Istituto Biochimico Nazionale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Biochimico Nazionale filed Critical Istituto Biochimico Nazionale
Priority to IT02173590A priority Critical patent/IT1243742B/en
Publication of IT9021735A0 publication Critical patent/IT9021735A0/en
Publication of IT9021735A1 publication Critical patent/IT9021735A1/en
Application granted granted Critical
Publication of IT1243742B publication Critical patent/IT1243742B/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention concerns pharmaceutical compositions based on calcitonin in aqueous solution at pH lying between 3.5 and 4.5, comprising: a calcitonin, alkyl esters of p-hydroxybenzoic acid, monobasic tromethamine citrate, monobasic meglumine citrate and citric acid in defined proportions. These compositions are particularly suitable for application to the nasal mucosa.
IT02173590A 1990-10-12 1990-10-12 Calcitonin-based pharmaceutical compositions IT1243742B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT02173590A IT1243742B (en) 1990-10-12 1990-10-12 Calcitonin-based pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02173590A IT1243742B (en) 1990-10-12 1990-10-12 Calcitonin-based pharmaceutical compositions

Publications (3)

Publication Number Publication Date
IT9021735A0 IT9021735A0 (en) 1990-10-12
IT9021735A1 IT9021735A1 (en) 1992-04-12
IT1243742B true IT1243742B (en) 1994-06-21

Family

ID=11186136

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02173590A IT1243742B (en) 1990-10-12 1990-10-12 Calcitonin-based pharmaceutical compositions

Country Status (1)

Country Link
IT (1) IT1243742B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014411A1 (en) * 2002-07-29 2004-02-19 Therapicon Srl Nasal peptide pharmaceutical formulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014411A1 (en) * 2002-07-29 2004-02-19 Therapicon Srl Nasal peptide pharmaceutical formulation

Also Published As

Publication number Publication date
IT9021735A1 (en) 1992-04-12
IT9021735A0 (en) 1990-10-12

Similar Documents

Publication Publication Date Title
GB2128088B (en) Oral mopidamol preparations
CA2024419A1 (en) Novel bivalent metal salts of n,n-di(carboxymethyl)-2-amino-3-cyano-4-carboxymethyl-5-carboxythiophene acid, process for their preparation and pharmaceutical compositions containing them
PH23256A (en) A process for the preparation of quinolone carboxylic acid derivatives
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
YU209288A (en) Process for producing compound for treating, which contains azelastin for use in nose and/or eye
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
PL358876A1 (en) Composition comprising free amino acids
BG103335A (en) Application of fumaric acid derivatives
ES2032382T3 (en) METHOD FOR PREPARING A MEDICATION FOR THE PREVENTION OR TREATMENT OF ENDOMETRIOSIS.
IL82615A0 (en) Aqueous steroid formulations for nasal administration
IL133614A0 (en) Medicinal compositions for application to mucosa
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
HU885915D0 (en) Process for the production of medical preparations for reducing intraocular pressure
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
GB8916734D0 (en) Pharmaceutical and dietary uses of fatty acids
IT1243742B (en) Calcitonin-based pharmaceutical compositions
NZ231320A (en) Aqueous oral preparations of diclofenac
KR910005886A (en) Stabilized Leukocyte Interferon
AU6724581A (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
JPS56110679A (en) 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it
IT1261959B (en) Pharmaceutical composition to improve the bioavailability of eicosapentanoic and decosahexanoic acid
DE69423623D1 (en) AMINO ACID SUPPLEMENT
JPS57149218A (en) Pharmaceutical preparation for oral administration
IT1226144B (en) Phosphoric di-ester of ursodeoxycholic acid and its derivatives, process for their preparation and therapeutic compositions which contain them as active substances

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030